Allergan Introduces Lastacaft for Ocular Itching
Allergan, Inc., launched Lastacaft (alcaftadine ophthalmic
solution) 0.25% for the prevention of ocular itching due to
allergic conjunctivitis, according to a news release.
Lastacaft, a new chemical entity with an affinity for H1, is
approved by the FDA for dosing once daily in patients aged
2 years or older. In clinic...